INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...
Vous n'êtes pas connecté
TUESDAY, Aug. 27, 2024 -- The U.S. Food and Drug Administration on Monday approved the expanded use of an automated insulin pump system to include those with type 2 diabetes.It's the first such system for use by people with the more prevalent type...
INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...
INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...
MONDAY, Sept. 9, 2024 -- Diabetics who fly with an insulin pump could find themselves with lower-than-normal blood sugar levels, a new study...
Diabetes affects over 37 million people in the U.S., with many of them living with type 2 diabetes. This form of diabetes used to be most common among...
Diabetes affects over 37 million people in the U.S., with many of them living with type 2 diabetes. This form of diabetes used to be most common among...
FRIDAY, Sept. 13, 2024 -- Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and...
FRIDAY, Sept. 13, 2024 -- Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and...
A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...
A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...
MONDAY, Sept. 16, 2024 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to...